These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 8631583)
1. Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers. Rusin MR; Okamoto A; Chorazy M; Czyzewski K; Harasim J; Spillare EA; Hagiwara K; Hussain SP; Xiong Y; Demetrick DJ; Harris CC Int J Cancer; 1996 Mar; 65(6):734-9. PubMed ID: 8631583 [TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers. Kawamata N; Miller CW; Koeffler HP Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415 [TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. Heidenreich A; Gaddipati JP; Moul JW; Srivastava S J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401 [TBL] [Abstract][Full Text] [Related]
4. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. Tahara H; Smith AP; Gaz RD; Arnold A J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819 [TBL] [Abstract][Full Text] [Related]
5. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004 [TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the INK4 family of genes in prostate carcinomas. Park DJ; Wilczynski SP; Pham EY; Miller CW; Koeffler HP J Urol; 1997 May; 157(5):1995-9. PubMed ID: 9112579 [TBL] [Abstract][Full Text] [Related]
7. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462 [TBL] [Abstract][Full Text] [Related]
8. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma. Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774 [TBL] [Abstract][Full Text] [Related]
9. Alterations of the p15, p16,and p18 genes in osteosarcoma. Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340 [TBL] [Abstract][Full Text] [Related]
10. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Drexler HG Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410 [TBL] [Abstract][Full Text] [Related]
11. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924 [TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas. Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056 [TBL] [Abstract][Full Text] [Related]
13. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Xiao S; Li D; Corson JM; Vijg J; Fletcher JA Cancer Res; 1995 Jul; 55(14):2968-71. PubMed ID: 7606711 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma. Child FJ; Scarisbrick JJ; Calonje E; Orchard G; Russell-Jones R; Whittaker SJ J Invest Dermatol; 2002 Jun; 118(6):941-8. PubMed ID: 12060387 [TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C). Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039 [TBL] [Abstract][Full Text] [Related]
16. Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers. Miyamoto H; Kubota Y; Fujinami K; Dobashi Y; Kondo K; Yao M; Shuin T; Hosaka M Oncol Res; 1995; 7(7-8):327-30. PubMed ID: 8747595 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma. Tasaka T; Berenson J; Vescio R; Hirama T; Miller CW; Nagai M; Takahara J; Koeffler HP Br J Haematol; 1997 Jan; 96(1):98-102. PubMed ID: 9012694 [TBL] [Abstract][Full Text] [Related]
18. Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias. Nakamaki T; Kawamata N; Schwaller J; Tobler A; Fey M; Pakkala S; Lee YY; Kim BK; Fukuchi K; Tsuruoka N Br J Haematol; 1995 Sep; 91(1):139-49. PubMed ID: 7577621 [TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors. Zariwala M; Liu E; Xiong Y Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224 [TBL] [Abstract][Full Text] [Related]
20. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Chaussade L; Eymin B; Brambilla E; Gazzeri S Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]